Zyden Gentec (Delisted) share price

BSE: 530091Pharmaceuticals & Biotechnology

Zyden Gentec Ltd. · Face value ₹2 · Listed May 1995

Last traded ₹0.87 on 28 Mar 2016

Delisted on 23 Nov 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

  1. Mar 2016

  2. Feb 2016

  3. Jan 2016

  4. Nov 2015

Share price history

Daily closes since Feb 2015, adjusted for splits and bonuses. Earlier closes are left out: on 18 Feb 2015 the price changed in a way no corporate action on record explains.

Daily close, ₹ per share

Results for the quarter to Dec 2015

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Net profit
₹0.16 Cr+53.9% on a year ago · −4.3% on the quarter before
Earnings per share
₹0.030.0% on the quarter before

From revenue to net profit, ₹ crore

  1. Other income+0.2
  2. Profit before tax0.2
  3. Net profit0.2

Zyden Gentec results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2015. Results for the quarter to Mar 2016 were due by 30 May 2016, 60 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
0.7−1.0Mar 130.5−0.1Jun 130.4−0.1Sep 130.20.1Dec 130.8−1.1Mar 140.30.1Jun 140.1Sep 140.1Dec 140.1Mar 150.2Jun 150.2Sep 150.2Dec 15
Peak revenue ₹0.83 Cr, quarter to Mar 2014; lowest ₹0.16 Cr, quarter to Dec 2013A loss in 4 of the 12 quarters shown

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
76.5%−152.4%−152.4%45.2%−142.5%−13.3%−14.0%76.5%−129.9%28.3%Mar 13Sep 13Mar 14Sep 14Mar 15Sep 15Dec 15
₹ croreMar 2011Jun 2011Sep 2011Dec 2011Mar 2012Jun 2012Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015
Revenue from operations––––3.692.382.461.980.730.480.360.160.830.34––––––
–––––2.562.23–1.84–––0.46–––––––
Materials and goods bought1.601.703.702.732.342.121.751.371.370.400.360.141.070.32––––––
Employee costs–––––0.170.20–0.21–––−0.13–––––––
Other expenses–––––0.360.28–0.27–––−0.40–––––––
Operating profit before depreciation–––––−0.180.23–−1.11–––0.38–––––––
Operating margin–––––−7.7%9.3%–−152.4%–––45.2%–––––––
Depreciation and amortisation0.160.150.150.14–0.060.06–0.080.060.060.060.180.060.060.06––––
Other income––––0.110.280.250.250.160.290.290.29−1.100.190.190.190.170.170.170.17
Finance costs0.320.310.350.270.280.090.150.150.01–––0.09–––0.03–––
Profit before tax−0.22−0.12−2.67−2.160.49−0.140.260.18−1.04−0.06−0.050.12−1.080.100.080.100.090.160.160.16
Tax––––−0.36–––––––––––––––
Tax rate––––−73.7%–––––––––––––––
Net profit−0.22−0.12−2.67−2.160.84−0.140.260.18−1.04−0.06−0.050.12−1.080.100.080.100.090.160.160.16
Net margin––––22.9%−5.7%10.7%9.1%−142.5%−13.3%−14.0%76.5%−129.9%28.3%––––––
Earnings per share–––––––––––––––––₹0.05₹0.03₹0.03
Earnings per share in rupees, restated for later splits and bonuses.

7 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
9.70.3Mar 080.0Mar 090.1Mar 100.0Mar 119.5−4.1Mar 127.5−0.7Mar 131.8−1.1Mar 14
Peak revenue ₹9.70 Cr, year to Mar 2008; lowest ₹1.83 Cr, year to Mar 2014A loss in 3 of the 7 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
12.5%−58.4%12.5%−31.0%−13.5%−16.2%3.4%−43.1%−9.7%−58.4%Mar 08Mar 09Mar 10Mar 11Mar 12Mar 13Mar 14

Results for the year to Mar 2014

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1.8
  2. Operating expenses−2.1
  3. Operating profit−0.3
  4. Depreciation−0.4
  5. Other income−0.2
  6. Finance costs−0.1
  7. Profit before tax−1.1
  8. Net profit−1.1

Profit and loss

Standalone, ₹ crore, years to March.

₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Revenue from operations9.7–––9.57.51.8
8.5–––12.58.62.1
Materials and goods bought7.022.114.412.59.96.6–
Employee costs––––1.00.8–
Other expenses––––1.61.2–
Operating profit before depreciation1.2–––−2.9−1.0−0.3
Operating margin12.5%–––−31.0%−13.5%−16.2%
Materials, % of revenue––––104.3%87.6%–
Employee costs, % of revenue––––10.4%10.1%–
Other expenses, % of revenue––––16.3%15.8%–
Depreciation and amortisation0.10.10.20.30.40.30.4
Operating profit after depreciation1.1–––−3.4−1.3−0.7
Other income–0.0––0.10.9−0.2
Finance costs0.10.20.40.81.20.40.1
One-off items−0.5––––––
Profit before tax0.41.10.70.0−4.5−0.7−1.1
0.10.10.1–−0.4––
Net profit0.30.00.10.0−4.1−0.7−1.1
Net margin3.4%–––−43.1%−9.7%−58.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2008 and Mar 2014 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2009, Mar 2010 and Mar 2011: the statement does not state its revenue or total expenses, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
––––––
As stated that year₹0.04₹0.02₹0.09−₹0.37−₹0.07−₹0.96
––––––
Market cap at the year end (₹ crore)–9.48.210.138.915.1
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.

RatioMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Revenue growth–––––−20.6%−75.8%
Net profit growth–−93.6%452.4%−62.1%–––
Interest cover14.6––––––
Interest cover is left blank for the years to Mar 2012, Mar 2013 and Mar 2014: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2014.

Measure3 years
Operating margin, average−20.2%
Net margin, average−37.0%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Effective tax ratePublished threshold 17.16 per cent23.118.5812.61––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Zyden Gentec share price by year

Each calendar year to 2016.

YearClose at year endChangeHighest closeLowest close
20160.87−17.1%1.350.87
20151.05–1.680.68
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2015 is from its first session, 18 Feb 2015. The 2016 close is its last trade, on 28 Mar 2016.

Recent sessions

The 10 trading days to 28 Mar 2016, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
28 Mar 20160.950.950.870.870.8712,355
21 Mar 20160.910.910.910.910.915,680
24 Feb 20160.870.950.870.950.9444,375
23 Feb 20160.990.990.910.910.9645,399
22 Feb 20160.950.950.950.950.95500
18 Feb 20160.951.000.951.000.9734,493
17 Feb 20160.931.000.931.000.9935,469
16 Feb 20160.980.980.970.970.9732,500
15 Feb 20160.990.990.910.950.916,106
12 Feb 20160.950.950.950.950.953,705
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
18 Feb 2015Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. The company made an announcement in time for trading that day or the trading day before. Earlier prices are not shown.
12 Oct 2012Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown.
27 Aug 2009Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown.
Where an event has no factor that can be worked out, the chart leaves out the closes before it.

Company details

BSE code
530091
ISIN
INE622B01045
Industry
Pharmaceuticals & Biotechnology
CIN
L67120RJ1994PLC008284
Corporate identity number, the registrar of companies' code for it
Incorporated
1994
Registered office
143/1, Deepshree Building, Kotri Road, Gumanpura, Kota 324007, Rajasthan
Share registrar
Aarthi Consultants Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments